274 related articles for article (PubMed ID: 15494550)
1. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
Jones CK; Peters SC; Shannon HE
J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interactions between the dual serotonergic, noradrenergic reuptake inhibitor duloxetine and the non-steroidal anti-inflammatory drug ibuprofen in inflammatory pain in rodents.
Jones CK; Peters SC; Shannon HE
Eur J Pain; 2007 Feb; 11(2):208-15. PubMed ID: 16542861
[TBL] [Abstract][Full Text] [Related]
3. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Jones CK; Eastwood BJ; Need AB; Shannon HE
Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
[TBL] [Abstract][Full Text] [Related]
4. Assessing carrageenan-induced locomotor activity impairment in rats: comparison with evoked endpoint of acute inflammatory pain.
Zhu CZ; Mills CD; Hsieh GC; Zhong C; Mikusa J; Lewis LG; Gauvin D; Lee CH; Decker MW; Bannon AW; Rueter LE; Joshi SK
Eur J Pain; 2012 Jul; 16(6):816-26. PubMed ID: 22337256
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
Miyazaki R; Yamamoto T
Anesth Analg; 2012 Jul; 115(1):182-8. PubMed ID: 22415534
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
[TBL] [Abstract][Full Text] [Related]
7. Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models.
Piesla MJ; Leventhal L; Strassle BW; Harrison JE; Cummons TA; Lu P; Whiteside GT
Brain Res; 2009 Oct; 1295():89-98. PubMed ID: 19651113
[TBL] [Abstract][Full Text] [Related]
8. Differential activities of intrathecal MK-801 or morphine to alter responses to thermal and mechanical stimuli in normal or nerve-injured rats.
Wegert S; Ossipov MH; Nichols ML; Bian D; Vanderah TW; Malan TP; Porreca F
Pain; 1997 May; 71(1):57-64. PubMed ID: 9200174
[TBL] [Abstract][Full Text] [Related]
9. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
[TBL] [Abstract][Full Text] [Related]
10. Persistent hyperalgesia in the cisplatin-treated mouse as defined by threshold measures, the conditioned place preference paradigm, and changes in dorsal root ganglia activated transcription factor 3: the effects of gabapentin, ketorolac, and etanercept.
Park HJ; Stokes JA; Pirie E; Skahen J; Shtaerman Y; Yaksh TL
Anesth Analg; 2013 Jan; 116(1):224-31. PubMed ID: 23223118
[TBL] [Abstract][Full Text] [Related]
11. Multiplicative interactions to enhance gabapentin to treat neuropathic pain.
Hayashida K; Eisenach JC
Eur J Pharmacol; 2008 Nov; 598(1-3):21-6. PubMed ID: 18822281
[TBL] [Abstract][Full Text] [Related]
12. Role of gabapentin in preventing fentanyl- and morphine-withdrawal-induced hyperalgesia in rats.
Wei X; Wei W
J Anesth; 2012 Apr; 26(2):236-41. PubMed ID: 22048285
[TBL] [Abstract][Full Text] [Related]
13. Gabapentin attenuates nociceptive behaviors in an acute arthritis model in rats.
Lu Y; Westlund KN
J Pharmacol Exp Ther; 1999 Jul; 290(1):214-9. PubMed ID: 10381778
[TBL] [Abstract][Full Text] [Related]
14. The combined predictive capacity of rat models of algogen-induced and neuropathic hypersensitivity to clinically used analgesics varies with nociceptive endpoint and consideration of locomotor function.
Munro G; Storm A; Hansen MK; Dyhr H; Marcher L; Erichsen HK; Sheykhzade M
Pharmacol Biochem Behav; 2012 May; 101(3):465-78. PubMed ID: 22366217
[TBL] [Abstract][Full Text] [Related]
15. Interaction between morphine and norketamine enantiomers in rodent models of nociception.
Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
Pharmacol Biochem Behav; 2008 Oct; 90(4):769-77. PubMed ID: 18582492
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin action and interaction on the antinociceptive effect of morphine on visceral pain in mice.
Meymandi MS; Sepehri G
Eur J Anaesthesiol; 2008 Feb; 25(2):129-34. PubMed ID: 17697423
[TBL] [Abstract][Full Text] [Related]
17. Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
Colpaert FC; Tarayre JP; Koek W; Pauwels PJ; Bardin L; Xu XJ; Wiesenfeld-Hallin Z; Cosi C; Carilla-Durand E; Assié MB; Vacher B
Neuropharmacology; 2002 Nov; 43(6):945-58. PubMed ID: 12423664
[TBL] [Abstract][Full Text] [Related]
18. In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
Urban L; Campbell EA; Panesar M; Patel S; Chaudhry N; Kane S; Buchheit KH; Sandells B; James IF
Pain; 2000 Dec; 89(1):65-74. PubMed ID: 11113294
[TBL] [Abstract][Full Text] [Related]
19. Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin.
Grégoire S; Michaud V; Chapuy E; Eschalier A; Ardid D
Pain; 2012 Aug; 153(8):1657-1663. PubMed ID: 22664319
[TBL] [Abstract][Full Text] [Related]
20. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
Kiguchi S; Imamura T; Ichikawa K; Kojima M
Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
